Postoperative Nausea and Vomiting (PONV) Market Report

Global Postoperative Nausea and Vomiting (PONV) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：189
  • REPORT CODE：GMM772060
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Postoperative Nausea and Vomiting (PONV) market report explains the definition, types, applications, major countries, and major players of the Postoperative Nausea and Vomiting (PONV) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Ani Pharmaceuticals

    • Merck

    • Helsinn Holding

    • GlaxoSmithKline

    • Sanofi

    • Eisai

    • F Hoffmann-La Roche

    • Novartis

    • Acacia Pharma

    • Camurus

    By Type:

    • Serotonin Antagonists

    • Steroids

    • Dopamine Antagonists

    • NK-1 Receptor Antagonists

    • Others

    • Non-pharmacologic Treatment

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies and Drug Stores

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Postoperative Nausea and Vomiting (PONV) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Postoperative Nausea and Vomiting (PONV) Outlook to 2028- Original Forecasts

    • 2.2 Postoperative Nausea and Vomiting (PONV) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Postoperative Nausea and Vomiting (PONV) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Postoperative Nausea and Vomiting (PONV) Market- Recent Developments

    • 6.1 Postoperative Nausea and Vomiting (PONV) Market News and Developments

    • 6.2 Postoperative Nausea and Vomiting (PONV) Market Deals Landscape

    7 Postoperative Nausea and Vomiting (PONV) Raw Materials and Cost Structure Analysis

    • 7.1 Postoperative Nausea and Vomiting (PONV) Key Raw Materials

    • 7.2 Postoperative Nausea and Vomiting (PONV) Price Trend of Key Raw Materials

    • 7.3 Postoperative Nausea and Vomiting (PONV) Key Suppliers of Raw Materials

    • 7.4 Postoperative Nausea and Vomiting (PONV) Market Concentration Rate of Raw Materials

    • 7.5 Postoperative Nausea and Vomiting (PONV) Cost Structure Analysis

      • 7.5.1 Postoperative Nausea and Vomiting (PONV) Raw Materials Analysis

      • 7.5.2 Postoperative Nausea and Vomiting (PONV) Labor Cost Analysis

      • 7.5.3 Postoperative Nausea and Vomiting (PONV) Manufacturing Expenses Analysis

    8 Global Postoperative Nausea and Vomiting (PONV) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Postoperative Nausea and Vomiting (PONV) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Postoperative Nausea and Vomiting (PONV) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Postoperative Nausea and Vomiting (PONV) Market Outlook by Types and Applications to 2022

    • 9.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Steroids Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global NK-1 Receptor Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Non-pharmacologic Treatment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies and Drug Stores Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Postoperative Nausea and Vomiting (PONV) Market Analysis and Outlook till 2022

    • 10.1 Global Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.2.2 Canada Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.2.3 Mexico Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.2 UK Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.3 Spain Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.4 Belgium Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.5 France Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.6 Italy Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.7 Denmark Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.8 Finland Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.9 Norway Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.10 Sweden Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.11 Poland Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.12 Russia Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.3.13 Turkey Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.2 Japan Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.3 India Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.4 South Korea Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.5 Pakistan Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.6 Bangladesh Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.7 Indonesia Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.8 Thailand Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.9 Singapore Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.10 Malaysia Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.11 Philippines Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.4.12 Vietnam Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.2 Colombia Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.3 Chile Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.4 Argentina Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.5 Venezuela Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.6 Peru Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.5.8 Ecuador Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.6.2 Kuwait Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.6.3 Oman Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.6.4 Qatar Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.7.2 South Africa Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.7.3 Egypt Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.7.4 Algeria Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

      • 10.8.2 New Zealand Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    11 Global Postoperative Nausea and Vomiting (PONV) Competitive Analysis

    • 11.1 Ani Pharmaceuticals

      • 11.1.1 Ani Pharmaceuticals Company Details

      • 11.1.2 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.1.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Merck

      • 11.2.1 Merck Company Details

      • 11.2.2 Merck Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Merck Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.2.4 Merck Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Helsinn Holding

      • 11.3.1 Helsinn Holding Company Details

      • 11.3.2 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.3.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 GlaxoSmithKline

      • 11.4.1 GlaxoSmithKline Company Details

      • 11.4.2 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.4.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sanofi

      • 11.5.1 Sanofi Company Details

      • 11.5.2 Sanofi Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sanofi Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.5.4 Sanofi Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Eisai

      • 11.6.1 Eisai Company Details

      • 11.6.2 Eisai Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Eisai Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.6.4 Eisai Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 F Hoffmann-La Roche

      • 11.7.1 F Hoffmann-La Roche Company Details

      • 11.7.2 F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.7.4 F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Novartis

      • 11.8.1 Novartis Company Details

      • 11.8.2 Novartis Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Novartis Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.8.4 Novartis Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Acacia Pharma

      • 11.9.1 Acacia Pharma Company Details

      • 11.9.2 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.9.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Camurus

      • 11.10.1 Camurus Company Details

      • 11.10.2 Camurus Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Camurus Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

      • 11.10.4 Camurus Postoperative Nausea and Vomiting (PONV) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Postoperative Nausea and Vomiting (PONV) Market Outlook by Types and Applications to 2028

    • 12.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Steroids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global NK-1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Non-pharmacologic Treatment Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Retail Pharmacies and Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Postoperative Nausea and Vomiting (PONV) Market Analysis and Outlook to 2028

    • 13.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.2 UK Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.5 France Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.3 India Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Postoperative Nausea and Vomiting (PONV)

    • Figure of Postoperative Nausea and Vomiting (PONV) Picture

    • Table Global Postoperative Nausea and Vomiting (PONV) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Postoperative Nausea and Vomiting (PONV) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Steroids Consumption and Growth Rate (2017-2022)

    • Figure Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global NK-1 Receptor Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Non-pharmacologic Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies and Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Table North America Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure United States Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Canada Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table Europe Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure Germany Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure UK Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Spain Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure France Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Italy Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Finland Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Norway Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Poland Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Russia Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table APAC Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure China Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Japan Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure India Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table South America Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure Brazil Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Chile Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Peru Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table GCC Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure Bahrain Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Oman Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table Africa Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure Nigeria Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table Oceania Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure Australia Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table Ani Pharmaceuticals Company Details

    • Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Merck Company Details

    • Table Merck Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Merck Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Helsinn Holding Company Details

    • Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Sanofi Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Eisai Company Details

    • Table Eisai Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Eisai Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table F Hoffmann-La Roche Company Details

    • Table F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Novartis Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Acacia Pharma Company Details

    • Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Table Camurus Company Details

    • Table Camurus Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Camurus Postoperative Nausea and Vomiting (PONV) Main Business and Markets Served

    • Table Camurus Postoperative Nausea and Vomiting (PONV) Product Portfolio

    • Figure Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK-1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-pharmacologic Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies and Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Table North America Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure United States Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure Germany Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure China Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure Australia Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US